Skip to content

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00662181
Enrollment
46
Registered
2008-04-21
Start date
2008-05-31
Completion date
2009-01-31
Last updated
2008-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-Associated Lipodystrophy Syndrome, HIV Infections

Keywords

growth hormone, quality of life, fat redistribution, sugar metabolism, fat metabolism, cytokines

Brief summary

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Interventions

None listed

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years of age * Participated in and completed the HIGH: low study * informed consent signed

Exclusion criteria

* Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study

Design outcomes

Primary

MeasureTime frame
Quality of life6 months follow-up

Secondary

MeasureTime frame
Metabolism6 months follow-up

Countries

Denmark

Contacts

Primary ContactKatrine MH Andersen, stud.med.
katrine.harries.andersen@hvh.regionh.dk45-36-322-108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026